Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

52.58
Delayed Data
As of Feb 12
 +0.40 / +0.77%
Today’s Change
45.45
Today|||52-Week Range
71.60
-11.24%
Year-to-Date

Today’s Trading

Previous close52.18
Today’s open52.53
Day’s range51.60 - 52.97
Volume9,976,155
Average volume (3 months)9,799,091
Market cap$86.0B
Dividend yield4.34%
Data as of 4:01pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+17.19%
Earnings growth (next 5 years)+16.70%
Revenue growth (last year)+14.52%
P/E ratio30.4
Price/Sales4.24
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+2.86+2.87%
LLYEli Lilly and Co-0.15-0.21%
GSKGlaxoSmithKline+0.61+1.56%
AZNAstraZeneca+0.51+1.75%
Data as of 4:03pm ET, 02/12/2016

Financials

Next reporting dateApril 22, 2016
EPS forecast (this quarter)$1.13
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers